Form of Proxy

RECURSION PHARMACEUTICALS, INC.

Notes

BD Client Code:

Client Name:

Number of Shares Held in a BD Nominee Company:

No.	Proposition		For	Against	Abstain
1	DIRECTOR Zachary Bogue, J.D.
2	DIRECTOR Zavain Dar
3	DIRECTOR Robert Hershberg MD PhD
4	Advisory vote to approve executive compensation as disclosed in the 2025 Proxy Statement.
5	Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2025.